Some cross-talk models between EGFR and SPHK1/S1P have been proposed previously, Estrada-Bernal, A et al[53] have reported that treatment of glioma cell lines with EGF led to increased expression and activity of SphK1. The gene discussed is EGFR; the disease is central nervous system cancer.